Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation

15 Feb 2023

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD), which starts with liver steatosis, is a growing worldwide epidemic responsible for chronic liver diseases. Among its risk factors, exposure to environmental contaminants, such as endocrine disrupting compounds (EDC), has been recently emphasized. Given this important public health concern, regulation agencies need novel simple and fast biological tests to evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue and Metabolism
Share to Birth, Development, and Health
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36835354
DOI: 10.3390/ijms24043942

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 RegulationPMID 36835354Read ↗

Zebrafish: An emerging model system to study liver diseases and related drug discoverySemantic proximity Read ↗

Gene expression markers in the zebrafish embryo reflect a hepatotoxic response in animal models and humans.Semantic proximity Read ↗

Zebrafish Larvae as a Predictive Model for the Risk of Chemical-Induced Cholestasis: Phenotypic Evaluation and Nomogram Formation.Semantic proximity Read ↗

Development of an Animal Model for Alcoholic Liver Disease in ZebrafishSemantic proximity Read ↗

Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity.Semantic proximity Read ↗

Organophosphate ester flame retardants and plasticizers affect the phenotype and function of HepG2 liver cells.Semantic proximity Read ↗

Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profilingSemantic proximity Read ↗

Evidence for Adverse Effects on Liver Development and Regeneration in Zebrafish by Decabromodiphenyl EthaneSemantic proximity Read ↗

A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity.Semantic proximity Read ↗

New tools to assess toxicity, bioaccessibility and uptake of chemical contaminants in meat and seafoodSemantic proximity Read ↗

Application of zebrafish to safety evaluation in drug discoverySemantic proximity Read ↗

Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.